• 제목/요약/키워드: $G{\alpha}_{16}$

검색결과 595건 처리시간 0.031초

중증 지역사회획득 폐렴환자의 예후에 영향을 미치는 면역지표에 대한 연구 (Prospective Study of the Immunologic Factors Affecting the Prognosis of Severe Community-Acquired Pneumonia)

  • 황재경;이호명;송광식;박계영;박정웅;박재경;정성환;안정열;서일혜;남귀현
    • Tuberculosis and Respiratory Diseases
    • /
    • 제50권4호
    • /
    • pp.437-449
    • /
    • 2001
  • 연구배경 : 중증 지역사회획득 폐렴환자에서 어떤 면역학적 요인이 중요한 예후 인자로 작용하는지와 그에 대한 예방과 개선방법을 알아보기 위해 연구를 시행하였다. 방 법 : 중증 폐렴환자 23명을 임상경과에 따라 회복군(n=16)과 사망군(n=7) 으로 나눈 후, 말초혈액에서 전혈구검사, 혈청 생화학검사, 면역글로블린, 보체, 림프구 아세포군 검사, 객담 및 혈액배양검사, 소변검사, 흉부 x-선 검사등을 시행하였다. 결 과 : 1) 양 군에서 말초혈액검사상 림프구감소증 소견이 있었다(림프구 평균 회복군 $995.6{\pm}505.7/mm^3$, 사망군 $624.0{\pm}287.6/mm^3$, p=0.18). 2) 양 군 모두 T 림프구가 감소되었고, 특히 사망군의 T 림프구수가 통계학적으로 유의하게 감소된 소견을 보여주었다(회복군 $723.6{\pm}406.5/mm^3$, 사망군 $295.9{\pm}203.0/mm^3$, p<0.05). 3) 혈청 생화학 검사상 단백질, 알부민이 정상치에 비해 감소되었으며(protein/ albumin 회복군 $6.0{\pm}1.0/2.7{\pm}0.7$, 사망군 $5.2{\pm}1.5/2.3{\pm}0.8$ 단위 : $g/d{\ell}$), 혈중 요소질소 수치는 회복군 $18.9{\pm}9.8mg/d{\ell}$, 사망군 $41.7{\pm}30.0mg/d{\ell}$으로 사망군에서 통계학적으로 의미있게 증가되었고(p<0.05), 혈청 크레아티닌은 회복군 $1.0{\pm}0.3mg/d{\ell}$, 사망군 $1.8{\pm}1.0mg/d{\ell}$으로, 사망군이 역시 의미있게 증가되어 있음을 보여주었다(p<0.05). 4) 면역글로블린 G는 회복군보다 사망군에서 유의하게 감소되어 있었다(IgG 회복군 $1433.0{\pm}729.5mg/d{\ell}$, 사망군 $849.1{\pm}373.1mg/d{\ell}$, p<0.05). 5) 보체 $C_3$, $C_4$의 수치가 모두 정상보다 떨어져 있었으며, 회복군에 비해 사망군에서 감소를 보였으나 통계학적 의의는 없었다. 6) Cytokine 연구 결과는 TNF-$\alpha$, IFN-$\gamma$, IL-2, IL-10을 측정하였으나 두 군간에 유의한 차이는 없었다. 7) 만성 간질환, 당뇨, 만성 폐쇄성 폐절환이 양 군에서 주요 기저질환이였다. 결 론 : 이상의 결과는 중증 지역사회획득 폐렴환자에서 T 림프구수치 특히, $T_8$ 림프구의 감소, $T_4/T_8$ 비율의 증가, 면역글로블린 G 감소, 혈중 요소질소 수치 증가, 혈청 크레아티닌이 증가된 소견은 나쁜 예후인자와 관련되는 것으로 추정된다.

  • PDF

어유(魚油)섭취가 흰쥐의 간과 뇌조직의 지질과산화물 형성과 항산화계에 미치는 영향 -성(性)의 차이를 중심으로- (Effect of Dietary Fish Oil on Lipid Peroxidation and Antiperoxidative System in Rat Liver and Brain -Sex-related Differences-)

  • 최경원;박명희;장경숙;조성희
    • 한국식품영양과학회지
    • /
    • 제16권2호
    • /
    • pp.147-155
    • /
    • 1987
  • 어유(魚油)에 포함된 $C20{\sim}22({\omega}3)$ 지방산을 섭취하였을 때, 간과 뇌조직의 지질과산화물 형성 및 항산화기능을 조사하기 위하여, 고등어유를 식이함량에 10%(w/w)되게 조제한 사료를, 70g 외의 암, 수컷의 취에게 주어 3개월간 사육하였다. 이 결과를 ${\omega}3$지방, ${\omega}6$지방, ${\omega}9$지방 및 포화지방과 비교하기 위하여, 다른 4군의 암, 수컷의 쥐들에게 들기름, 대두유, 채종유 및 쇠기름을 각각 첨가한 조제식이를 주어 같은 기간동안 사육하였다. 간조직의 지질과산화들 농도가 고등어유군에서 현저히 높은 반면, ${\alpha}-tocopherol$과 환원형 glutathione (GSH)의 양은 낮았다. 이 현상은 암컷에서가 숫컷에서보다 분명히 드러났고, 고등어유군 외의 타군간의 차이는 숫컷에서 약간 보여 졌으나 일관성은 없었다. 모든 식이군의 간조직 GSH농도는 숫컷에서가 암컷에서보다 낮았으나 산화형 glutathione (GSSG) 농도는 식이나 성에 따른 차이가 없었다. 뇌조직에서는 식이지방에 따른 지질과산화물과 ${\alpha}-tocopherol$ 농도의 차이가 발견되지 않았다. 간과 뇌의 양 조직에서 glutathione peroxidase나 superoxide dismutase의 활성이 식이에 따라 변화는 없었으나 glutathione peroxidase의 활성은 숫컷에서가 암컷에서보다 일관성있게 낮았다. 따라서 이 연구에서는 성(性)에 따른 항산화 기능에 차이가 있다는 것을 밝혔으며, 어유(魚油)를 통하여 C2O 이상의 ${\omega}3$ 다불포화지방산를 섭취할 때, 총 불포화도가 유사하거나 높은 $C18:2({\omega}6)$$C18:3({\omega}3)$ 지방산 섭취시보다 체내에서 많은 지질과산화들을 형성하며, 그에 따른 항산화물질의 소모가 크다는 것이 주목된다고 하겠다.

  • PDF

In vitro에서 조릿대, 연근과 연잎이 인슐린 작용 및 분비에 미치는 영향 (Effect of Sasa Borealis and White Lotus Roots and Leaves on Insulin Action and Secretion In Vitro)

  • 고병섭;전동화;장진선;김주호;박선민
    • 한국식품과학회지
    • /
    • 제38권1호
    • /
    • pp.114-120
    • /
    • 2006
  • 백련 뿌리 및 잎과 조릿대는 과거부터 약용으로 사용해 왔지만 아직까지 연구도 많이 이루어지지 않았고, 항당뇨 효과에 대한 연구도 거의 없었다. 본 연구에서는 백련 뿌리 및 잎과 조릿대의 추출물과 분획물이 in vitro에서 인슐린 작용, 인슐린 분비 또는 탄수화물의 소화에 효과적인지를 조사함으로 항당뇨에 효과적인지 여부를 조사하였다. 백련 뿌리 및 잎과 조릿대의 추출물은 각각 물로 추출하여 항당뇨 효과를 조사하였다. 또한 백련 뿌리 및 잎과 조릿대의 3 : 2 : 3으로 혼합하여 물로 추출한 후 이를 메탄올과 물을 섞은 용액으로 단계별로 XAD-4 column으로 분획하였다. 백련 뿌리 및 잎과 조릿대의 추출물과 혼합물의 분획물은 고농도(1 mg/mL)에서도 MTT 방법으로 측정하였을 때 세포 독성을 나타내지 않았다. 백련 뿌리와 조릿대 물추출물은 인슐린 작용을 향상시키는 효능이 있었고, 백련잎 물추출물은 ${\alpha}-amylase$를 억제하여 탄수화물의 소화 흡수를 지연시켰다. 이에 백련 뿌리 및 잎과 조릿대를 3 : 2 : 3으로 혼합하였을 때 20과 80% 메탄올층은 3T3-L1 지방세포에 처리하였을 때 인슐린의 작용을 향상시켜 포도당의 흡수를 증가시키는 효과가 인슐린을 10 nM을 처리한 것 만큼 효과적으로 포도당 흡수를 증가시켰다. 이 층에는 3T3-L1 섬유아세포에 분화 유도물질과 함께 처리하였을 때 $PPAR-{\gamma}$ agonist인 rosiglitazone과 마찬가지로 지방 세포로의 분화를 촉진시키고 지방의 축적도 증가시켰다. 그러므로 80% 메탄올 층에는 $PPAR-{\gamma}$ agonist로 작용하는 물질이 함유되어 있을 가능성이 높다. 베타세포라인인 Min6 세포에 백련 뿌리 및 잎과 조릿대의 혼합물의 분획물을 처리한 후 저농도와 고농도 포도당 자극시 인슐린 분비를 측정하였을 때 두 농도에서 모두 인슐린 분비에 영향을 미치지 않았다. 또한 백련 뿌리 및 잎과 조릿대의 혼합물의 20, 60과 80% 메탄올 분획층은 탄수화물의 소화에 작용하는 효소인 ${\alpha}-amylase$의 활성을 16% 정도를 억제하는 효과가 있었다. 결론적으로 백련 뿌리 및 잎과 조릿대의 추출물과 분획물에는 인슐린 분비나 탄수화물의 소화에 관여하는 성분이 없지만, 인슐린 작용을 향상시키는 인슐린 민감성 물질이 함유되어 있을 가능성이 높다.

딜라트렌 정(카르베딜롤 25 mg)에 대한 카베롤 정의 생물학적 동등성 (Bioequivalence of Carvelol Tablet to Dilatrend Tablet (Carvedilol 25 mg))

  • 조혜영;이문석;박순철;임동구;문재동;이용복
    • Journal of Pharmaceutical Investigation
    • /
    • 제31권4호
    • /
    • pp.289-295
    • /
    • 2001
  • Carvedilol is an antihypertensive and antianginal compound that combines nonselective beta-adrenoceptor blocking and vasodilation properties and is devoid of intrinsic sympathomimetic activity. The purpose of the present study was to evaluate the bioequivalence of two carvedilol tablets, $Dilatrend^{TM}$ (Chong Kun Dang Pharmaceutical Co., Ltd.) and $Carvelol^{TM}$ (Dae Won Pharmaceutical Co., Ltd.), according to the prior and revised guidelines of Korea Food and Drug Administration (KFDA). The carvedilol release from the two carvedilol tablets in vitro was tested using KP VII Apparatus II method with various different kinds of dissolution media (pH 1.2, 4.0, 6.8 buffer solution, water and blend of PSB80 into water). Eighteen normal male volunteers, $24.22{\pm}1.86$ years in age and $64.81{\pm}4.56\;kg$ in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After one tablet containing 25 mg of carvedilol was orally administered, blood was taken at predetermined time intervals and the concentrations of carvedilol in serum were determined using HPLC method with fluorescence detector. The dissolution profiles of two carvedilol tablets were very similar at all dissolution media. Besides, the pharmacokinetic parameters such as $AUC_t$, $C_{max}$ and $T_{max}$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters using non-transformed and logarithmically transformed $AUC_t$ and $C_{max}$. The results showed that the differences in $AUC_t$, $C_{max}$ and $T_{max}$ between two tablets based on the $Dilatrend^{TM}$ were 2.23%, -2.00% and 0.00%, respectively. Minimum detectable differences $({\Delta})$ at ${\alpha}=0.05$ and $1-{\beta}=0.8$ were less than 20% (e.g., 13.55% and 17.61% for $AUC_t$ and $C_{max}$, respectively). The powers $(l-{\beta})$ at ${\alpha}=0.05$, ${\Delta}=0.2$ for $AUC_t$ and $C_{max}$ were 98.08% and 88.81%, respectively. The 90% confidence intervals were within ${\pm}20%$ (e.g., $-5.69{\sim}10.16$ and $-12.30{\sim}8.30$ for $AUC_t$ and $C_{max}$, respectively). There were no sequence effect between two tablets in logarithmically transformed $AUC_t$ and $C_{max}$. The 90% confidence intervals using logarithmically transformed were within the acceptance range of log(0.8) to log(1.25) (e.g., $0.95{\sim}1.11$ and $0.89{\sim}1.09$ for $AUC_t$ and $C_{max}$, respectively). Two parameters met the criteria of prior and revised KFDA guideline for bioequivalence, indicating that $Carvelol^{TM}$ tablet is bioequivalent to $Dilatrend^{TM}$ tablet.

  • PDF

니세틸 정(아세틸-엘-카르니틴 500 mg)에 대한 뉴로세틸 정의 생물학적 동등성 (Bioequivalence of Neurocetil Tablet to Nicetile Tablet (Acetyl-L-Carnitine 500 mg))

  • 조혜영;김은아;정현철;심영순;임동구;오인준;문재동;이용복
    • Journal of Pharmaceutical Investigation
    • /
    • 제31권1호
    • /
    • pp.49-55
    • /
    • 2001
  • Acetyl-L-carnitine (ALC), an endogenous component of the L-carnitine family, is naturally occurring molecule synthesized from L-carnitine (LC) by carnitine acetyl transferase. ALC has been shown to improve the cognitive performance of patients suffering from dementia of the Alzheimer's type and proposed for treating Alzheimer's disease in pharmacological doses. The purpose of the present study was to evaluate the bioequivalence of two ALC tablets, $Nicetile^{TM}$ (Dong-A pharmaceutical Co., Ltd.) and $Neurocetil^{TM}$ (Kyung-Dong Pharmaceutical Co., Ltd.), according to the guidelines of Korea Food and Drug Administration. Twenty six normal male volunteers, $22.80{\pm}2.76$ year in age and $63.07{\pm}7.98\;kg$ in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After one tablet containing 500 mg of ALC was orally administered, blood was taken at predetermined time intervals and the concentrations of ALC in serum were determined using HPLC with fluorescence detector. Because of the presence of endogenous ALC, the calibration was performed using dialyzed serum. Pharmacokinetic parameters such as $AUC_t$, $C_{max}\;and\;T_{max}$ were calculated and ANOVA was utilized for the statistical analysis of the parameters. The results showed that the differences in $AUC_t$, $C_{max}\;and\;T_{max}$ between two tablets were 2.72%, -0.65% and -8.42%, respectively, when calculated against the $Nicetile^{TM}$ tablet. The powers $(1-{\beta})$ for $AUC_t\;and\;C_{max}$ were 94.87% and 87.17%, respectively. Minimum detectable differences $({\Delta})$ at ${\alpha}=0.05$ and $1-{\beta}=0.8$ were less than 20% (e.g., 15.58% and 19.16% $AUC_t\;C_{max}$, respectively). The 90% confidence intervals were within ${\pm}20%$ (e.g., $-11.84{\sim}6.41$ and $-10.57{\sim}11.88$for $AUC_t\;and\;C_{max}$, respectively). Two parameters met the criteria of KFDA for bioequivalence, indicating that $Neurocetil^{TM}$ tablet is bioequivalent to $Nicetile^{TM}$ tablet.

  • PDF

디스그렌 캅셀(트리플루살 300 mg)에 대한 티그린 캅셀의 생물학적 동등성 (Bioequivalence of Tigrin Capsule to Disgren Capsule (Triflusal 300 mg))

  • 김수진;심영순;손선미;임동구;문재동;이용복
    • Journal of Pharmaceutical Investigation
    • /
    • 제29권4호
    • /
    • pp.355-360
    • /
    • 1999
  • Triflusal is a new antithrombotic agent which inhibits both platelet cyclooxygenase and c-AMP phosphodiesterase activity. The purpose of the present study was to evaluate the bioequivalence of two triflusal capsules, $Disgren^{TM}$ (Myung-In Pharmaceutical Co., Ltd.) and $Tigriri^{TM}$ (Hana Pharmaceutical Co., Ltd.) according to the guidelines of Korea Food and Drug Administration (KFDA). Eighteen normal male volunteers, $22.94{\pm}1.83$ in age and $63.7l{\pm}10.43$ kg in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After one capsule containing 300 mg of triflusal was orally administered, blood was taken at predetermined time intervals and the concentrations of triflusal in serum were determined using HPLC method with UV detector. Pharmacokinetic parameters such as $AUC_t$ $C_{max}$ and $T_{max}$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters. The results showed that the differences in $AUC_t$ $C_{max}$ and $T_{max}$ between two capsules were -0.30%, 0.81 % and -3.03%, respectively when calculated against the $Disgren_{TM}$ capsule. The powers $(1-{\beta})$ for $AUC_t$ $C_{max}$ and $T_{max}$ were 98.29%,84.73% and 81.02%, respectively. Minimum detectable differences $({\Delta})$ at ${\alpha}=0.1$ and $1-{\beta}=0.8$ were all less than 20% (e.g., 12.91%, 18.46% and 19.65% for $AUC_t$ $C_{max}$ and $T_{max}$ respectively). The 90% confid,ence intervals were all within ${\pm}20%$(e.g., $-8.97{\sim}8.37$, $-11.58{\sim}13.22$ and $-16.23{\sim}10.17$ for $AUC_t$ $C_{max}$ and $T_{max}$, respectively). All of the above parameters ($1-{\beta}, {\Delta}$ and 90% confidence intervals) met the criteria of KFDA for bioequivalence, indicating that $Tigriri^{TM}$ capsule is bioequivalent to $Disgren^{TM}$ capsule.

  • PDF

조프란 정(온단세트론 8 mg)에 대한 하나 온단세트론 정의 생물학적 동등성 (Bioequivalence of Hana Ondansetron Tablet to Zofran Tablet (Ondansetron 8 mg))

  • 조혜영;김수진;심영순;임동구;오인준;문재동;이용복
    • Journal of Pharmaceutical Investigation
    • /
    • 제30권3호
    • /
    • pp.213-218
    • /
    • 2000
  • Ondansetron is a potent, highly selective 5-hydroxytryptamine3(5-HT3) receptor- antagonist, for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiography, and the treatment of post-operative nausea and vomiting. The purpose of the present study was to evaluate the bioequivalence of two ondansetron tablets, $Zofran^{TM}$, (Glaxo Wellcome Korea Ltd.) and Hana ondansetron (Hana Pharmaceutical Co., Ltd.), according to the guidelines of Korea Food and Drug Administration (KFDA). Eighteen normal male volunteers, $23.56{\pm}1.79$ year in age and $67.35{\pm}8.35\;kg$ in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After one tablet containing 8 mg of ondansetron was orally administered, blood was taken at predetermined time intervals and the concentrations of ondansetron in serum were determined using HPLC with UV detector. Pharmacokinetic parameters such as $AUC_t,\;C_{max}\;and\;T_{max}$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters. The results showed that the differences in $AUC_t,\;C_{max}\;and\;T_{max}$ between two tablets were 7.53%, -0.23% and -3.92%, respectively when calculated against the $Zofran^{TM}$, tablet. The powers $(1-{\beta})$ for $AUC_t,\;C_{max}\;and\;T_{max}$ were above 99.00%, above 99.00% and 84.99%, respectively. Minimum detectable differences $(\Delta)\;at\;{\alpha}=0.1\;and\;1-{\beta}=0.8$ were all less than 20% (e.g., 12.25%, 10.88% and 18.37% for $AUC_t,\;C_{max}\;and\;T_{max}$, respectively). The 90% confidence intervals were all within ${\pm}20%$ (e.g., $-0.70{\sim}15.76,\;-7.53{\sim}7.08\;and\;-16.27{\sim}8.42\;for\;AUC_t,\;C_{max}\;and\;T_{max}$, respectively). All of the above parameters met the criteria of KFDA for bioequivalence, indicating that Hana ondansetron tablet is bioequivalent to $Zofran^{TM}$, tablet.

  • PDF

Effect of Calmodulin on Ginseng Saponin-Induced $Ca^{2+}$-Activated $Cl^{-}$ Channel Activation in Xenopus laevis Oocytes

  • Lee Jun-Ho;Jeong Sang-Min;Lee Byung-Hwan;Kim Jong-Hoon;Ko Sung-Ryong;Kim Seung-Hwan;Lee Sang-Mok;Nah Seung-Yeol
    • Archives of Pharmacal Research
    • /
    • 제28권4호
    • /
    • pp.413-420
    • /
    • 2005
  • We previously demonstrated the ability of ginseng saponins (active ingredients of Panax ginseng) to enhance $Ca^{2+}$-activated $Cl^{-}$ current. The mechanism for this ginseng saponin-induced enhancement was proposed to be the release of $Ca^{2+}$ from $IP_{3}-sensitive$ intracellular stores through the activation of PTX-insensitive $G\alpha_{q/11}$ proteins and PLC pathway. Recent studies have shown that calmodulin (CaM) regulates $IP_{3}$ receptor-mediated $Ca^{2+}$ release in both $Ca^{2+}-dependent$ and -independent manner. In the present study, we have investigated the effects of CaM on ginseng saponin-induced $Ca^{2+}$-activated $Cl^{-}$ current responses in Xenopus oocytes. Intraoocyte injection of CaM inhibited ginseng saponin-induced $Ca^{2+}$-activated $Cl^{-}$ current enhancement, whereas co-injection of calmidazolium, a CaM antagonist, with CaM blocked CaM action. The inhibitory effect of CaM on ginseng saponin-induced $Ca^{2+}$-activated $Cl^{-}$ current enhancement was dose- and time-dependent, with an $IC_{50} of 14.9\pm3.5 {\mu}M$. The inhibitory effect of CaM on saponin's activity was maximal after 6 h of intraoocyte injection of CaM, and after 48 h the activity of saponin recovered to control level. The half-recovery time was calculated to be $16.7\pm4.3 h$. Intraoocyte injection of CaM inhibited $Ca^{2+}$-induced $Ca^{2+}$-activated $Cl^{-}$ current enhancement and also attenuated $IP_{3}$-induced $Ca^{2+}$-activated $Cl^{-}$ current enhancement. $Ca^{2+}$/CaM kinase II inhibitor did not inhibit CaM-caused attenuation of ginseng saponin-induced $Ca^{2+}$-activated $Cl^{-}$ current enhancement. These results suggest that CaM regulates ginseng saponin effect on $Ca^{2+}$-activated $Cl^{-}$ current enhancement via $Ca^{2+}$-independent manner.

에어탈 정(아세클로페낙 100 mg)에 대한 에이서 캅셀의 생물학적 동등성 (Bioequivalence of Acer Capsule to Airtal Tablet (Aceclofenac 100 mg))

  • 조혜영;김수진;오인준;문재동;이용복
    • 한국임상약학회지
    • /
    • 제12권1호
    • /
    • pp.22-28
    • /
    • 2002
  • Aceclofenac, 2-[(2',6'-dichlorphenyl)amino]phenylacetoxiacetic acid, is a new nonsteroidal anti-inflammatory drug that belongs to the family of phenylacetic acids. It shows good tolerance and potent analgesic/antiinflammatory properties, and acts on cartilaginous chondriocytes, stimulating their repair mechanism. The purpose of the present study was to evaluate the bioequivalence of two aceclofenac products, $Airtal^{TM}$ tablet (Daewoong Pharmaceutical Co.) and $Acer^{TM}$ capsule (Kyungdong Pharmaceutical Co.), according to the guideliner of Korea Food and Drug Administration (KFDA). The aceclofenac release from the two aceclofenac products in vitro was tested using KP VII Apparatus II method at pH 7.8 dissolution media. Sixteen normal male volunteers, $23.13\pm2.03$ years in age and $66.33\pm7.08$ kg in body weight, were divided into two groups and a randomized $2\times2$ cross-over study was employed. After one tablet or capsule containing 100 mg of aceclofenac was orally administered, blood was taken at predetermined time intervals and the concentrations of aceclofenac in serum were determined using HPLC with UV detector. The dissolution profiles of the two aceclofenac products were very similar at pH 7.8 dissolution media. The pharmacokinetic parameters such as $AUC_t,\;C_{max}\;and\;T_max$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters. The results showed that the differences in $AUC_t,\;C_{max}\;and\;T_{max}$ between two products were $6.50\%,\;-1.06\%\;and\;11.96\%$ respectively, when calculated against the $Airtal^{TM}$ tablet. The powers $(1-\beta)\;for\;AUC_t,\;C_{max}\;were\;89.82\%\;and\;82.84\%$, respectively. Minimum detectable differences $(\Delta)\;at\;\alpha=0.05\;and\;1-\beta=0.8$ were less than $20\%\;(e.g.,\;17.51\%\;and\;19.30\%\;for\;AUC_t,\;C_{max}$, ). The $90\%$ confidence intervals were within $\pm20\%\;(e.g.,\;-3.73\%\sim16.73\%\;and\;-12.34\%\sim10.22\%\;for\;AUC_t,\;C_{max},\;respectively)$. Two parameters met the criteria of KFDA for bioequivalence, indicating that $Acer^{TM}$ capsule is bioequivalent to $Airtal^{TM}$ tablet.

  • PDF

고온내성 연료용 알코올 효모균주 Saccharomyces cerevisiae KNU5377에서 HSF1 유전자의 변이주 구축 (Construction of hsf1 Knockout-mutant of a Thermotolerant Yeast Strain Saccharomyces cerevisiae KNU5377)

  • 김일섭;윤혜선;최혜진;손호용;유춘발;김종국;진익렬
    • 생명과학회지
    • /
    • 제16권3호
    • /
    • pp.454-458
    • /
    • 2006
  • 출아효모인 Sacharomyces cerevisiae S288C균주를 이용한 효모의 게놈이 완성된 후 S. cerevisiae는 다양한 연구 모델로 이용되어져 왔다. 현재까지 효모를 이용한 기능 유전체학 측면에서의 연구는 laboratory strainin인 S288C 균주 또는 그 유래의 균주들이다. 그러나 자연에서 분리된 효모 또는 산업적으로 이용되어지고 있는 S. cerevisiae의 유전학 측면에서의 연구는 낮은 포자형성률 및 형질전환률, 그리고 S288C 균주와의 게놈상의 상이성 때문에 거의 이루어지지 않고 있다. 여기서 우리 연구진은 자연에서 분리된 Saccharomyces cerevisiae KNU5377 균주를 이용하여 random spore analysis를 통해 MATa 및 $MAT{\alpha}$ 타입의 각각의 haploid cell을 분리 후 이미 보고된 KanMX module를 가지고 round PCR기법에 의한 short flanking homology 기법을 이용하여 전사조절인자인 HSF1 유전자가 치환된 변이주를 구축할 수 있었다. 덧붙여, 모든 유전자에 이 기법을 적용할 수는 없다는 것을 확인하였다. 앞으로 이 변이주를 통해 기능 유전체학적인 측면에서 이 유전자의 스트레스와의 관련성을 연구하고자 한다.